The most critical decision you have to make when importing data in CDD is whether you should commit the data or not. The previous version of the report gave you access to all the information but it did a bad job highlighting the important facts that should drive your decision. The new single-page report groups events by type and places them in one of the following categories: Noteworthy, Suspicious, Errors, and, in some rare circumstances, Ambiguous.




Other posts you might be interested in
View All Posts
CDD Insights
7 min
November 25, 2025
Drug Discovery Industry Roundup with Barry Bunin — November 25 2025
Read More
Webinars
1 min
November 22, 2025
From Hype to Practice: Where AI Actually Helps in Drug Discovery - 2025 Canadian UGM Replay
Read More
CDD Insights
10 min
November 14, 2025
Synthetic Peptides, Nucleotides, Antibodies and Their Drug Conjugates: For Biologists, Chemists and Computers
Read More

